In this review:
- Pooled analysis of neoadjuvant carboplatin in early-stage TNBC
- Epirubicin, cyclophosphamide, taxanes and carboplatin for early-stage TNBC
- Impact of immune checkpoint inhibition on fertility
- Menopausal hormone therapy and risk of breast cancer with pathogenic BRCA
- Tucatinib as maintenance for HER2+ metastatic breast cancer
- Sacituzumab govitecan in HR+/ HER2− metastatic breast cancer
- Giredestrant in oestrogen receptor-positive, HER2− early breast cancer
- Omission of sentinel lymph node biopsy in T1-2 node-negative breast cancer
- Less invasive axillary surgical staging in early breast cancer
- Acupuncture for cancer-related cognitive difficulties
Please login below to download this issue (PDF)